Ignite Creation Date:
2025-12-25 @ 4:55 AM
Ignite Modification Date:
2025-12-26 @ 3:55 AM
Study NCT ID:
NCT04298918
Status:
TERMINATED
Last Update Posted:
2021-11-08
First Post:
2020-03-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Trastuzumab Emtansine in Patients With Previously Treated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-23
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-04
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-05
First Submit QC Date:
None
Study First Post Date:
2020-03-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-10-08
Results First Submit QC Date:
None
Results First Post Date:
2021-11-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-08
Last Update Post Date:
2021-11-08
Last Update Post Date Type:
ACTUAL